Relative bioavailability of midazolam following sublingual versus oral administration in healthy volunteers.
- 1 January 1988
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Journal of Pharmacobio-Dynamics
- Vol. 11 (3) , 206-209
- https://doi.org/10.1248/bpb1978.11.206
Abstract
The extent of bioavailability of midazolam following sublingual and oral administration were evaluated. Three healthy volunteers received a single 15-mg dose of midazolam maleate by sublingual and oral routes on two occasions in a crossover design. Concentrations of midazolam in plasma during 4 h after each dose were measured by gas-liquid chromatography with an electron-capture detector. The mean UC0-4 value following sublingual administration was significantly greater than that following oral administration (14889 vs 3594 ng .cntdot. min/ml, p < 0.05). The peak plasma concentration after sublingual dose was also significantly higher than that after oral administration (p < 0.05). The mean AUC0-4 value of midazolam after sublingual administration was increased four times compared with that after oral administration, possibly due to avoidance of first-pass effect. Thus, the clinical effects of midazolam may likewise be enhanced by sublingual administration of midazolam.This publication has 7 references indexed in Scilit:
- Cimetidine and ranitidine increase midazolam bioavailabilityClinical Pharmacology & Therapeutics, 1987
- Enhanced Bioavailability of Triazolam Following Sublingual Versus Oral AdministrationThe Journal of Clinical Pharmacology, 1986
- Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.Gut, 1986
- Sublingual Flunitrazepam for PremedicationActa Anaesthesiologica Scandinavica, 1985
- Midazolam kinetics in women of two age groupsClinical Pharmacology & Therapeutics, 1983
- SUBLINGUAL LORAZEPAM: A BETTER PREMEDICATION?British Journal of Anaesthesia, 1983
- Midazolam kineticsClinical Pharmacology & Therapeutics, 1981